ArticleCureus2025
REAC Neurobiological Modulation With Neuro Postural Optimization (NPO) and Neuro Muscular Optimization (NMO) in Early Post-stroke Recovery: Functional Outcomes, Mechanistic Rationale, and Implications for Neurorehabilitation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stroke remains a leading cause of long-term disability worldwide, and early intervention is critical for optimizing neurorehabilitative outcomes by capitalizing on the heightened neuroplasticity of the acute and subacute phases. This study aimed to evaluate whether the integration of Radio Electric Asymmetric Conveyer (REAC) neurobiological modulation protocols, Neuro Postural Optimization (NPO) and Neuro Muscular Optimization (NMO), into early post-stroke rehabilitation can accelerate and enhance functional recovery compared to conventional rehabilitation alone. Thirteen patients (nine males, four females; age range: 56-86 years; mean: 74) received a single NPO session, followed by an intensive cycle of 10 NMO sessions distributed over five to six consecutive days. Treatment efficacy was evaluated using the Barthel Index (BI), the items from the mobility section of the Fugl-Meyer Assessment (FMA) motor function scale, and the assessment of functional dysmetria (FD). The REAC-treated cohort demonstrated marked improvements, with BI increasing from a mean of 33 to 68 and the items from the mobility section of the FMA from 9.0 to 17.3. FD, present in all patients at baseline, resolved completely after the NPO session and remained absent. A historical control group (n=13; 8 males, 5 females; age range: 56-94 years; mean: 76), matched for age and clinical condition, underwent standard rehabilitation without REAC interventions. This group showed more modest gains (BI from 36 to 67; items from the mobility section of the FMA from 8.9 to 15.3) despite a longer average hospitalization duration (34.4 days vs. 30.8 days in the REAC group). No adverse effects or complications were reported in the REAC-treated patients. These findings highlight the potential of REAC NPO and NMO protocols to support and enhance functional recovery when applied in the critical early stages of stroke rehabilitation. Further prospective controlled trials are warranted to validate these results and explore the mechanistic underpinnings of REAC-mediated neuromodulation in post-stroke recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.